NO20052264D0 - Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser - Google Patents
Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelserInfo
- Publication number
- NO20052264D0 NO20052264D0 NO20052264A NO20052264A NO20052264D0 NO 20052264 D0 NO20052264 D0 NO 20052264D0 NO 20052264 A NO20052264 A NO 20052264A NO 20052264 A NO20052264 A NO 20052264A NO 20052264 D0 NO20052264 D0 NO 20052264D0
- Authority
- NO
- Norway
- Prior art keywords
- pregahalin
- fibromyalgia
- disorders
- derivatives
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Transplantation (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43349102P | 2002-12-13 | 2002-12-13 | |
US48774003P | 2003-07-16 | 2003-07-16 | |
PCT/IB2003/005712 WO2004054566A1 (en) | 2002-12-13 | 2003-12-03 | Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052264D0 true NO20052264D0 (no) | 2005-05-10 |
NO20052264L NO20052264L (no) | 2005-09-12 |
Family
ID=32600153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052264A NO20052264L (no) | 2002-12-13 | 2005-05-10 | Pregabalinderivater for behandling av fibromyalgi og andre forstyrrelser |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090203782A1 (no) |
EP (2) | EP1572188A1 (no) |
JP (1) | JP2006513257A (no) |
KR (1) | KR20050085636A (no) |
CN (1) | CN101862317A (no) |
AU (1) | AU2003303040B2 (no) |
BR (1) | BR0317253A (no) |
CA (1) | CA2505788A1 (no) |
MX (1) | MXPA05006320A (no) |
NO (1) | NO20052264L (no) |
NZ (1) | NZ540591A (no) |
PL (1) | PL377520A1 (no) |
RU (2) | RU2353358C2 (no) |
TW (1) | TW200423925A (no) |
WO (1) | WO2004054566A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1608357A4 (en) * | 2003-03-31 | 2008-03-26 | Xenoport Inc | TREATMENT OR PREVENTION OF HITZEWALLUNGEN USING PRODRUGS OF GABA ANALOGUE |
EP1675582A1 (en) * | 2003-09-12 | 2006-07-05 | Warner-Lambert Company LLC | Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
US20070141684A1 (en) | 2005-12-21 | 2007-06-21 | Pfizer Inc | Preparation of gamma-amino acids having affinity for the alpha-2-delta protein |
CN106132406B (zh) * | 2014-02-03 | 2020-03-27 | 夸德里加生物科学公司 | 作为化疗剂的β-取代的γ-氨基酸和类似物 |
AU2015210638B2 (en) | 2014-02-03 | 2017-07-20 | Quadriga Biosciences, Inc. | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents |
AR105592A1 (es) | 2015-08-03 | 2017-10-18 | Quadriga Biosciences Inc | b-AMINOÁCIDOS b-SUSTITUIDOS Y ANÁLOGOS COMO AGENTES QUIMIOTERAPÉUTICOS Y USOS DE LOS MISMOS |
CN115739134A (zh) * | 2022-11-24 | 2023-03-07 | 贵州大学 | 一种利用三氯化钌废弃物制备氯乙烯合成用复合催化剂的方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2460891C2 (de) | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4087544A (en) | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
CA2134674C (en) | 1992-05-20 | 2004-12-21 | Richard B. Silverman | Gaba and l-glutamic acid analogs for antiseizure treatment |
TW444018B (en) | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
TW336932B (en) | 1992-12-17 | 1998-07-21 | Pfizer | Amino-substituted pyrazoles |
DE69323768T2 (de) | 1992-12-17 | 1999-07-01 | Pfizer | Pyrrolopyrimidine als crf antagonisten |
WO1994013661A1 (en) | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Substituted pyrazoles as crf antagonists |
WO1994013643A1 (en) | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrazoles and pyrazolopyrimidines having crf antagonist activity |
US5670539A (en) * | 1993-07-21 | 1997-09-23 | New York State Office Of Mental Health | Treatment of movement disorders using large neutral amino acids |
US6372792B1 (en) * | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
USRE41920E1 (en) * | 1996-07-24 | 2010-11-09 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
DE69737719D1 (de) | 1996-10-23 | 2007-06-21 | Warner Lambert Co | Substituierte gamma-aminobuttersäurederivate als arzneimittel |
US6127418A (en) * | 1997-08-20 | 2000-10-03 | Warner-Lambert Company | GABA analogs to prevent and treat gastrointestinal damage |
GEP20094817B (en) | 1997-10-27 | 2009-11-10 | Warner Lambert Co | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
NZ509231A (en) | 1998-07-09 | 2003-08-29 | Warner Lambert Co | Use of GABA analogs to treat insomnia |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
EP1169060B1 (en) * | 1999-04-09 | 2005-08-31 | Euro-Celtique S.A. | Sodium channel blocker compositions and the use thereof |
CZ301608B6 (cs) | 1999-06-10 | 2010-04-28 | Warner-Lambert Company | Derivát 3-propyl gamma-aminomáselné kyseliny a farmaceutický prostredek s jeho obsahem |
US6642398B2 (en) * | 1999-06-10 | 2003-11-04 | Warner-Lambert Company | Mono-and disubstituted 3-propyl gamma-aminobutyric acids |
US7164034B2 (en) * | 1999-06-10 | 2007-01-16 | Pfizer Inc. | Alpha2delta ligands for fibromyalgia and other disorders |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
AU767119B2 (en) * | 1999-07-22 | 2003-10-30 | University Of Rochester | Method of treating symptoms of hormonal variation, including hot flashes |
US6281207B1 (en) * | 1999-09-15 | 2001-08-28 | Reed Richter | Treatment of movement disorders by administration of mirtazapine |
HN2000000224A (es) | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
GB2362646A (en) | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
US20020099013A1 (en) * | 2000-11-14 | 2002-07-25 | Thomas Piccariello | Active agent delivery systems and methods for protecting and administering active agents |
IL145584A0 (en) * | 2000-10-02 | 2002-06-30 | Pfizer Prod Inc | Nmda nr2b antagonists for treatment |
US20020165246A1 (en) * | 2001-03-05 | 2002-11-07 | Andrew Holman | Administration of sleep restorative agents |
CZ299755B6 (cs) * | 2001-05-25 | 2008-11-12 | Warner-Lambert Company Llc | Kapalná farmaceutická kompozice obsahující analoggama-aminomáselné kyseliny, zpusob její prípravy a použití |
-
2003
- 2003-12-03 CA CA002505788A patent/CA2505788A1/en not_active Abandoned
- 2003-12-03 PL PL377520A patent/PL377520A1/pl not_active Application Discontinuation
- 2003-12-03 KR KR1020057010833A patent/KR20050085636A/ko not_active Application Discontinuation
- 2003-12-03 NZ NZ540591A patent/NZ540591A/en unknown
- 2003-12-03 MX MXPA05006320A patent/MXPA05006320A/es active IP Right Grant
- 2003-12-03 BR BR0317253-8A patent/BR0317253A/pt not_active IP Right Cessation
- 2003-12-03 EP EP03813230A patent/EP1572188A1/en not_active Withdrawn
- 2003-12-03 CN CN201010165706A patent/CN101862317A/zh active Pending
- 2003-12-03 WO PCT/IB2003/005712 patent/WO2004054566A1/en active Application Filing
- 2003-12-03 AU AU2003303040A patent/AU2003303040B2/en not_active Ceased
- 2003-12-03 JP JP2005502471A patent/JP2006513257A/ja active Pending
- 2003-12-03 EP EP09175270A patent/EP2172197A1/en not_active Withdrawn
- 2003-12-03 RU RU2005118081/14A patent/RU2353358C2/ru not_active IP Right Cessation
- 2003-12-12 TW TW092135197A patent/TW200423925A/zh unknown
-
2005
- 2005-05-10 NO NO20052264A patent/NO20052264L/no not_active Application Discontinuation
-
2008
- 2008-10-13 RU RU2008140653/15A patent/RU2008140653A/ru unknown
-
2009
- 2009-04-20 US US12/426,501 patent/US20090203782A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004054566A1 (en) | 2004-07-01 |
AU2003303040A1 (en) | 2004-07-09 |
CA2505788A1 (en) | 2004-07-01 |
EP2172197A1 (en) | 2010-04-07 |
PL377520A1 (pl) | 2006-02-06 |
NO20052264L (no) | 2005-09-12 |
JP2006513257A (ja) | 2006-04-20 |
MXPA05006320A (es) | 2005-08-26 |
KR20050085636A (ko) | 2005-08-29 |
US20090203782A1 (en) | 2009-08-13 |
RU2353358C2 (ru) | 2009-04-27 |
BR0317253A (pt) | 2005-11-01 |
AU2003303040B2 (en) | 2009-04-23 |
NZ540591A (en) | 2008-03-28 |
RU2008140653A (ru) | 2010-04-20 |
CN101862317A (zh) | 2010-10-20 |
TW200423925A (en) | 2004-11-16 |
EP1572188A1 (en) | 2005-09-14 |
RU2005118081A (ru) | 2006-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1663978T3 (da) | Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser | |
NO20052760D0 (no) | Fremgangsmate for behandling av kreft og beslektede fremgangsmater. | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
NO20050570L (no) | Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander | |
ZA200504724B (en) | Pregabalin derivatives for the treatment of fibromyalgia and other disorders | |
DE60319865D1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
IS7699A (is) | Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma | |
NO20040097L (no) | Kombinasjoner for behandling av inflammatoriske forstyrrelser | |
NO20041216L (no) | Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt | |
IS8451A (is) | Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma | |
IS8410A (is) | Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma | |
DK1459750T3 (da) | (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser | |
NO20055832D0 (no) | Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme | |
NO20055152D0 (no) | Karbonstyrilderivater og humor stabiliserende midler for behandling av humor forstyrrelser | |
EA200500098A1 (ru) | Лекарственное средство и способ лечения патологического синдрома | |
NO20051521L (no) | Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt | |
NO20053874L (no) | Formulering og metoder for behandling av thrombocytemi | |
NO20052264D0 (no) | Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser | |
NO20041386L (no) | Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser | |
NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
NO20014648L (no) | Forbindelser og metoder for behandling av astma, allergi og inflammatoriske sykdommer | |
NO20052859D0 (no) | Fremgangsmate for fremstilling av resperidon og intermediater derav | |
NO20041214L (no) | Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer | |
DK1478438T3 (da) | Fremgangsmåder og sammensætninger til behandling af astma | |
NO20033498L (no) | Fremgangsmåte for behandling og törking av trevirke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |